The incidence of diabetes mellitus has reached epidemic levels in recent years, affecting one in every 10 adults globally in 2021. Ninety percent of these individuals have Type 2 Diabetes (T2D)...
The first glucagon-like peptide-1 (GLP-1)-based therapeutic was approved by Health Canada in 2011 for the treatment of hyperglycemia in patients with Type 2 diabetes. Little was it suspected at...
November is National Diabetes Awareness Month. It therefore timely to consider what diabetes actually is, why we should care, and how it can be treated. Diabetes, or more technically, diabetes...
RSS